HAK12 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
HAK12 antibody; Os08g0206400 antibody; LOC_Os08g10550 antibody; OsJ_26409Putative potassium transporter 12 antibody; OsHAK12 antibody
Target Names
HAK12
Uniprot No.

Target Background

Function
High-affinity potassium transporter.
Database Links
Protein Families
HAK/KUP transporter (TC 2.A.72.3) family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is HAK12 and why is it significant in plant research?

HAK12 is a putative potassium transporter found primarily in plants such as Zea mays (maize). This protein belongs to the high-affinity K+ transport system and plays a critical role in potassium homeostasis in plants . The significance of HAK12 lies in its role in regulating potassium uptake, particularly under low potassium conditions, which is essential for various physiological processes including plant growth, stress responses, and crop yield.

What detection methods are optimal for HAK12 antibody-based experiments?

Based on similar antibody systems, optimal detection methods for HAK12 antibodies include:

  • Western blotting (optimal dilution typically 1:1000-1:5000)

  • Immunoprecipitation (typical dilution 1:150)

  • Immunohistochemistry (optimal dilution 1:1000)

  • Immunocytochemistry (typical dilution 1:1000-1:2000)

The selection of detection method should be based on experimental objectives and sample preparation. For example, Western blotting is ideal for quantifying total HAK12 protein levels, while immunohistochemistry is better suited for localization studies in plant tissues .

How should researchers validate HAK12 antibody specificity in plant tissues?

Validation of HAK12 antibody specificity should follow these methodological steps:

  • Positive controls: Use recombinant HAK12 protein or tissues known to express high levels of HAK12

  • Negative controls: Use tissues from HAK12 knockout plants or tissues where HAK12 is not expressed

  • Peptide competition assays: Pre-incubate antibody with the immunizing peptide before application

  • Multiple antibody validation: Compare results from different HAK12 antibody clones or polyclonal antibodies from different sources

  • Cross-reactivity testing: Assess potential cross-reactivity with other closely related potassium transporters (HAK family members)

Western blot analysis should reveal a single band of the expected molecular weight for HAK12 (~80-90 kDa depending on species) .

How should experimental protocols be modified when working with HAK12 antibodies across different plant species?

When adapting HAK12 antibody-based protocols across plant species, researchers should:

  • Sequence homology analysis: Determine the sequence conservation of HAK12 epitopes between target species

  • Titration experiments: Perform antibody dilution series to determine optimal concentration for each species

  • Tissue-specific extraction optimization: Modify protein extraction buffers based on tissue-specific requirements:

Plant SpeciesRecommended Extraction BufferOptimal Antibody Dilution (WB)Notes
Zea mays (maize)50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, protease inhibitor cocktail1:1000Standard conditions
Oryza sativa (rice)50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, protease inhibitor cocktail1:800May require gentler detergent
Arabidopsis thaliana100 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM EDTA, 10 mM DTT, 0.5% Triton X-100, protease inhibitor cocktail1:500Higher antibody concentration typically needed
  • Fixation protocol adjustments: Modify fixation conditions for immunohistochemistry based on plant tissue type and cell wall composition .

What are the critical factors for optimizing immunoprecipitation of HAK12 from plant tissues?

Successful immunoprecipitation of HAK12 from plant tissues requires attention to these critical factors:

  • Protein extraction conditions: Use gentle detergents (0.5-1% NP-40 or Triton X-100) to maintain native protein structure

  • Antibody binding conditions: Optimize incubation time (4-16 hours) and temperature (4°C is recommended)

  • Bead selection: Protein A/G beads for polyclonal antibodies; Protein G for most monoclonal antibodies

  • Cross-linking considerations: Consider cross-linking antibodies to beads to prevent antibody contamination in eluates

  • Elution strategy:

    • Mild: Non-denaturing elution with competing peptide

    • Moderate: Low pH glycine buffer (pH 2.5-3.0)

    • Harsh: SDS-PAGE sample buffer with reducing agents

Pre-clearing lysates with beads alone can significantly reduce non-specific binding. For plant tissues with high polysaccharide or phenolic compound content, include additives such as polyvinylpyrrolidone (PVP) or polyvinylpolypyrrolidone (PVPP) in extraction buffers .

How can researchers develop epitope tagging strategies for HAK12 to overcome antibody limitations?

When developing epitope tagging strategies for HAK12:

  • Tag selection considerations:

    • HA tag (YPYDVPDYA) is well-established with multiple validated antibodies available

    • Position the tag to minimize interference with protein function:

      • N-terminus tagging is preferred if C-terminus is involved in protein-protein interactions

      • C-terminus tagging is preferred if N-terminus contains signal peptides

      • Internal tagging may be considered if both termini are functionally important

  • Validation of tagged constructs:

    • Perform complementation assays in HAK12-deficient plants to ensure tagged protein retains functionality

    • Compare subcellular localization patterns of tagged vs. untagged protein

    • Assess protein-protein interactions using co-immunoprecipitation

  • Tag detection optimization:

    • Anti-HA antibody clones such as 16B12 or 12CA5 have been extensively validated

    • Recommended dilutions for anti-HA antibodies:

      • Western blot: 1:1000-1:5000

      • Immunoprecipitation: 1:50-1:150

      • Immunofluorescence: 1:800-1:1600

What approaches can address cross-reactivity issues with HAK family members when using HAK12 antibodies?

To address cross-reactivity with other HAK family members:

  • Epitope mapping and selection:

    • Identify unique sequences specific to HAK12 that differ from other HAK transporters

    • Design antibodies against these regions, preferably in hydrophilic domains

    • Avoid conserved functional domains shared among HAK family members

  • Advanced validation techniques:

    • Use CRISPR/Cas9 knockout lines as negative controls

    • Perform immunodepletion experiments with recombinant HAK12 protein

    • Use mass spectrometry to confirm identity of immunoprecipitated proteins

  • Computational prediction tools:

    • Employ DeepAb or similar deep learning models to assess antibody specificity profiles and potential cross-reactivity

    • Use sequence alignment tools to identify unique HAK12 epitopes with minimal homology to other HAK transporters

  • Differential expression systems:

    • Use heterologous expression systems to express individual HAK family members

    • Test antibody reactivity against each expressed protein to identify cross-reactivity

How should researchers interpret variable HAK12 antibody staining patterns in different plant tissues?

When interpreting variable HAK12 antibody staining patterns:

  • Technical variability assessment:

    • Control for fixation effects: Overfixation can mask epitopes while underfixation may lead to poor tissue preservation

    • Optimize antigen retrieval methods for different tissue types

    • Standardize image acquisition parameters across samples

  • Biological interpretation framework:

    • Context-dependent expression: HAK12 expression varies based on potassium availability and plant developmental stage

    • Cell-type specific regulation: Consider differential expression in different cell types within the same tissue

    • Post-translational modifications: Modifications may affect epitope accessibility and antibody binding

  • Quantification approaches:

    • Use signal intensity normalization with internal controls

    • Apply appropriate statistical tests for comparing staining patterns

    • Consider advanced image analysis methods for pattern recognition

What strategies can resolve contradictory results between HAK12 antibody detection and mRNA expression data?

To resolve contradictions between protein and mRNA data:

  • Technical verification:

    • Validate antibody specificity using multiple approaches

    • Confirm mRNA detection methods (primers, probes) target the correct transcript variant

    • Check for technical artifacts in both protein and mRNA detection methods

  • Biological explanations:

    • Post-transcriptional regulation: mRNA abundance may not correlate with protein levels due to:

      • Variable translation efficiency

      • Differential protein stability and turnover rates

      • microRNA regulation of translation

  • Integrated analysis approaches:

    • Temporal resolution: Analyze time-course data to detect delays between transcription and translation

    • Spatial resolution: Compare tissue-specific patterns at cellular/subcellular levels

    • Functional validation: Use genetic approaches (overexpression, knockout) to confirm protein function

    • Consider protein complex formation, which may mask epitopes in certain conditions

How can researchers enhance HAK12 antibody thermostability and affinity for challenging experimental conditions?

To enhance HAK12 antibody performance:

  • Computational design approaches:

    • Implement deep learning models like DeepAb to predict stabilizing mutations

    • Target framework regions outside the complementarity-determining regions (CDRs)

    • Focus on improving thermodynamic stability (ΔG) rather than just melting temperature (Tm)

  • Experimental enhancement strategies:

    • CDR grafting onto stable framework regions

    • Introduction of stabilizing disulfide bonds

    • Surface charge optimization to reduce aggregation propensity

  • Validation metrics:

    • Measure thermal stability parameters (Tm, Tonset, Tagg)

    • Assess colloidal stability under various buffer conditions

    • Quantify binding kinetics (kon, koff) and affinity (KD)

Based on similar antibody engineering studies, researchers can achieve significant improvements:

  • 91% of designed variants show increased thermal stability

  • 94% exhibit improved colloidal stability

  • Up to 21-fold increase in binding affinity can be achieved while maintaining favorable developability profiles

What methodological approaches are recommended for developing HAK12 monoclonal antibodies with enhanced variant-resistant properties?

For developing variant-resistant HAK12 monoclonal antibodies:

  • Epitope targeting strategy:

    • Target conserved functional domains of HAK12 that are less likely to tolerate mutations

    • Identify epitopes that span multiple conserved regions

    • Use structural biology approaches to identify buried, functionally critical regions

  • Isolation and screening framework:

    • Implement high-throughput surface plasmon resonance (HT-SPR) to identify antibodies with distinct binding profiles

    • Organize antibodies into "communities" based on competition profiles

    • Screen against engineered HAK12 variants with mutations in key regions

  • Antibody cocktail development:

    • Combine antibodies targeting different epitopes to prevent escape by mutations

    • Select antibodies from different binding communities to ensure broad coverage

    • Test combinations against artificially generated HAK12 variants with multiple mutations

  • Validation against natural variants:

    • Test antibody efficacy against HAK12 variants from different plant species

    • Assess binding to HAK12 proteins with post-translational modifications

    • Quantify neutralization potency against functional variants

This methodological framework has been successful in developing variant-resistant antibodies in other systems, with significant improvements in recognition breadth and neutralization potency.

How are advanced structural biology techniques advancing our understanding of HAK12 antibody epitope binding?

Current structural biology approaches for HAK12 antibody research include:

  • Cryo-electron microscopy (Cryo-EM):

    • Enables visualization of antibody-HAK12 complexes at near-atomic resolution

    • Particularly valuable for membrane proteins like HAK12 that are challenging to crystallize

    • Provides insights into conformational epitopes spanning multiple domains

  • X-ray crystallography applications:

    • Offers atomic-level resolution of antibody binding sites

    • Reveals key interaction residues for structure-based antibody improvement

    • Helps identify conserved epitopes across HAK family members

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Maps conformational changes upon antibody binding

    • Identifies regions with altered solvent accessibility

    • Provides complementary data to static structural techniques

  • Methodological integration:

    • Combining multiple structural approaches produces comprehensive binding models

    • Computational approaches can predict binding sites when experimental data is limited

    • Molecular dynamics simulations provide insights into binding kinetics and flexibility

What are the emerging applications of HAK12 antibodies in studying plant stress responses and climate adaptation mechanisms?

Emerging applications of HAK12 antibodies in plant stress research include:

  • Potassium sensing networks:

    • Tracking HAK12 protein levels and modifications under varying potassium conditions

    • Correlating HAK12 expression with drought and salinity tolerance mechanisms

    • Identifying regulatory proteins that interact with HAK12 during stress responses

  • Spatiotemporal dynamics analysis:

    • Using fluorescently labeled antibodies to track HAK12 trafficking in response to stress

    • Monitoring tissue-specific HAK12 expression during developmental stages

    • Analyzing membrane domain localization changes during stress adaptation

  • Crop improvement applications:

    • Screening germplasm collections for HAK12 variants associated with stress tolerance

    • Validating HAK12 modification in gene-edited crops with improved nutrient efficiency

    • Developing HAK12-based biomarkers for selecting climate-resilient crop varieties

  • Novel methodological approaches:

    • Integrating antibody-based proteomics with phenotyping platforms

    • Combining HAK12 protein analysis with ion flux measurements

    • Using HAK12 antibodies in single-cell analyses of stress responses

These applications demonstrate how HAK12 antibodies are contributing to our understanding of fundamental plant biology and supporting agricultural adaptation to changing environmental conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.